达芬奇手术机器人系统在胃癌根治性切除术患者治疗中的效果观察  

Observation on the Therapeutic Effect of Da Vinci Surgical Robot System in Patients Undergoing Radical Gastrectomy for Gastric Cancer

作　　者：梁峰 LIANG Feng(The First Affiliated Hospital of Fujian Medical University,Fujian Fuzhou 350000)

机构地区：[1]福建医科大学附属第一医院,福建福州350000

出　　处：《中国医疗器械信息》2023年第23期122-124,共3页China Medical Device Information

摘　　要：目的:探讨达芬奇手术机器人系统在胃癌根治性切除术患者治疗中的应用价值。方法:选取2020年1月~2021年12月本院胃癌根治性切除术患者80例,按随机法分为观察组与对照组,各40例。对照组采用腹腔镜下胃癌根治性切除术,观察组采用达芬奇手术机器人系统配合胃癌根治性切除术开展。对比两组手术情况、术后情况、炎性因子水平(C反应蛋白、白细胞介素-6)、免疫功能[T淋巴细胞亚群(CD4^(+)、CD8^(+))水平]及并发症发生率。结果:观察组术中出血量、淋巴结清扫总数及第一站淋巴结清扫数量均少于对照组(P<0.05);观察组首次排气、进食时间及引流管拔除时间短于对照组,术后引流量少于对照组(P<0.05);术后3d,观察组C反应蛋白、白细胞介素-6水平低于对照组(P<0.05);术后3d,观察组CD4^(+)水平高于对照组,CD8^(+)水平低于对照组(P<0.05);观察组并发症发生率7.50%与对照组15.00%对比无显著差异(P>0.05)。结论:达芬奇手术机器人系统应用于胃癌根治性切除术患者可改善围手术期情况,缓解炎症,提升免疫功能,存在安全性。Objective:To explore the application value of the Da Vinci surgical robot system in the treatment of patients undergoing radical gastrectomy for gastric cancer.Methods:80 patients with gastric cancer undergoing radical resection in our hospital from January 2020 to December 2021 were randomly divided into an observation group and a control group,with 40 patients in each group.The control group underwent laparoscopic radical resection of gastric cancer,while the observation group underwent radical resection of gastric cancer using the Da Vinci surgical robot system.The operation condition,postoperative condition,inflammatory factor level(CRP,Interleukin 6),immune function[T lymphocyte subsets(CD4^(+),CD8^(+))level]and complication rate were compared between the two groups.Results:The intraoperative bleeding,total number of lymph node dissection,and number of lymph node dissection in the observation group were all lower than those in the control group(P<0.05);The observation group had shorter first exhaust,eating time,and drainage tube removal time than the control group,and the postoperative drainage flow was lower than the control group(P<0.05);3 days after surgery,the levels of CRP and IL-6 in the observation group were lower than those in the control group(P<0.05);3 days after surgery,the CD4^(+)level in the observation group was higher than that in the control group,while the CD8^(+)level was lower than that in the control group(P<0.05);There was no significant difference in the incidence of complications between the observation group of 7.50%and the control group of 15.00%(P>0.05).Conclusion:The application of the Da Vinci surgical robot system in patients undergoing radical gastrectomy for gastric cancer can improve perioperative conditions,alleviate inflammation,enhance immune function,and have safety.

关 键 词：胃癌 根治性切除术 达芬奇手术机器人系统 免疫功能 

分 类 号：TP242.3[自动化与计算机技术—检测技术与自动化装置]